CN
489-39-4
应用筛选条件
关键词:'489-39-4'
显示 1-22 共 22 条结果 关于 "489-39-4" 范围 技术文档
Data Sheet - P1431
D.M., J. Biol. Chem., 255(3), 962-975
(1980).
43. Klee, C.B. et al., Ann. Rev. Biochem., 49, 489-525
(1980).
44. Klee, C.B. et al., Proc. Nat. Acad. Sci. USA, 76(12),
6270-6273 (1979).
45
XP725 Antibody Number-Lot Number 071M4826
-f g-h
1.1 1 2 3 4 25 26 27 28 49 50 51 52 73 74 75 76
1.2 5 6 7 8 29 30 31 32 53 54 55 56 77 78 79 80
1.3 9 10 11 12
Application Note - Detection of Tumor-Associated Antigen Gene Expression in Peripheral Blood by RT-PCR
antigen recognized
by autologous cytolytic T-lymphocytes on HLA-A2
melanomas. J. Exp. Med. 178: 489–495.
4. Coulie, P.G., Brichard, V., Van Pel, A., Wölfel, T.,
Schneider, J., Traversari, C., Mattei, S
PKH Dye Reference Guide
fluorescent
stains on thawed cryopreserved bovine
sperm cells. J.Histochem.Cytochem. 1991;
39: 485-489.
163. Embleton MJ, Charleston A, Affleck K:
Efficacy and selectivity of
monoclonal-antibody-targeted
59505 Galactosyltransferase Kit
et al., Mol. Cell. Biochem., 1984, 62, 37.
47 H.A. Nunez, R. Barker, Biochemistry, 1980, 19, 489.
48 I.P. Trayer, R.L. Hill., J. Biol. Chem., 1970, 245, 5057.
Product Information Sheet - 10843555001
tablets in a glass vial
3 × 20 tablets in glass vials
20 tablets in EASYpacks
11 873 580 001
05 056 489 001
04 693 132 001
cOmplete Lysis-M (for
mammalian cell lysis)
1 kit (200 ml lysis reagent
Human Cytokine Gene Expression Analysis Utilizing Novel STATE and HPSA Fluorescent Assay Technology
Cytokine Network,
9, 663-668 (2002).
4. Debets, J. et al. Plasma tumor necrosis factor and mortality in critically
ill septic patients. Critical Care Medicine, 17, 489-493 (1989).
5. Steer, J.H. et al
Protein Tyrosine Phosphatases- Potential Roles in Disease
J.E., et al., Mol. Cell. Biol., 21, 2393-2403 (2001).
61. Horiba, M., et al., J. Clin. Invest., 105, 489-497 (2000).
62. Qi, M., et al., J. Biol. Chem., 276, 15868-15875 (2001).
63. Maeda, N., et al., J.
User Guide - Milli-Q® HX and HR 7000 Series
244/537
Milli-Q® HX 7150 105 / 232 124 / 273 255/562
Milli-Q® HR 7060 72 / 159 91 / 200 222/489
Milli-Q® HR 7120 75 / 165 94 / 207 225/496
Milli-Q® HR 7170 78 /
XP725 Antibody List Lot 089K4791
n/d
751 Pinin P0084 5411 PNN M NP_002678.2 y n/d n/d
38 ARTS A3720 5414 4-Sep P NP_001185642.1 y n/d n/d
39 ARTS A4471 5414 4-Sep M NP_001185642.1 y n/d n/d
461 a-MSH M0939 5443 POMC P NP_000930.1
XP725 Antibody List Lot 129K4830
n/d
751 Pinin P0084 5411 PNN M NP_002678.2 y n/d n/d
38 ARTS A3720 5414 4-Sep P NP_001185642.1 y n/d n/d
39 ARTS A4471 5414 4-Sep M NP_001185642.1 y n/d n/d
461 a-MSH M0939 5443 POMC P NP_000930.1
XP725 Antibody List Lot 129K4831
n/d
751 Pinin P0084 5411 PNN M NP_002678.2 y n/d n/d
38 ARTS A3720 5414 4-Sep P NP_001185642.1 y n/d n/d
39 ARTS A4471 5414 4-Sep M NP_001185642.1 y n/d n/d
461 a-MSH M0939 5443 POMC P NP_000930.1
Halal Certificate
486. CIS-4-DECENAL 93%, STABILIZED W326402 B21092 HC-22SI8Q19
487. CIS-4-HEPTENAL 98%, FCC, FG W328901 B60926 HC-22SIEM85
488. CIS-5-OCTEN-1-OL 98% W372218 A60734 HC-22SIBQ64
489. CIS-6-NONEN
Halal Certificate
486. CIS-4-DECENAL 93%, STABILIZED W326402 B21092 HC-23SIYP97
487. CIS-4-HEPTENAL 98%, FCC, FG W328901 B60926 HC-23SIJI64
488. CIS-5-OCTEN-1-OL 98% W372218 A60734 HC-23SIPN43
489. CIS-6-NONEN
3D BIOPRINTING: Printing a Brighter Future
Illeperuma, W. R.; Chaudhuri, O.; Oh, K. H.;
Mooney, D. J.; Vlassak, J. J.; Suo, Z. Nature 2012, 489, 133.
(225) Fuchs, S.; Shariati, K.; Ma, M. Adv. Healthc.Mater. 2020, 9, 1901396.
(226) Oveissi
3D BIOPRINTING: Printing a Brighter Future
Illeperuma, W. R.; Chaudhuri, O.; Oh, K. H.;
Mooney, D. J.; Vlassak, J. J.; Suo, Z. Nature 2012, 489, 133.
(225) Fuchs, S.; Shariati, K.; Ma, M. Adv. Healthc.Mater. 2020, 9, 1901396.
(226) Oveissi
inNovations Newsletter #18
, J. (1996)
Curr. Opin. Biotechnol. 7, 489–493.
3. Goldman, E. E., Rosenberg, A. H.,
Zubay, G., and Studier, F. W. (1995)
J. Mol. Biol. 245, 467–473.
4. Baca, A. M. and Hol, W. G. J. (2000)
Int
XP725 Worksheet for Lot Number 071M4826
3 1 4 E2F2 E8776
485 3 3 1 5 E2F3 E8651
486 3 3 1 6 E2F3 E8651
487 3 3 1 7 E2F4 E8526
488 3 3 1 8 E2F4 E8526
489 3 3 2 1 E6AP E8655
490 3 3 2 2 E6AP
List of Antibodies
NBS1 (Nibrin) N9287 M y n/d n/d
487 NBS1 (Nibrin) N3037 P y n/d n/d
488 NBS1 (Nibrin) N3162 P y n/d y
489 Nck-2 N2911 M y n/d y
490 Nedd 8 N2786 M y n/d n/d
491 Nerve Growth Factor-β
Apoptosis - Antibodies, Reagents and Kits
Growth. Mol. Cell., 18: 13-24, 2005.
4. Vivanco, I and Sawyer, C.L. The Phosphatidylinositol 3-Kinase-AKT
Pathway in Human Cancer. Nature Reviews Cancer, 2: 489-501, 2002.
10
Antibody-based
XP725 Antibody List
ACTR3,Actr3 NP_076224.1,NP_112330.1,NP_005712.1 M y y y
38 ARTS A3720 5414 4-Sep NP_536341.1 P y n/d n/d
39 ARTS A4471 5414 4-Sep NP_536341.1 M y n/d n/d
40 ASAP1/Centaurin β4 A4227 50807, 314961, 13196
XP725 Antibody List 013M4793
ACTR3,Actr3 NP_076224.1,NP_112330.1,NP_005712.1 M y y y
38 ARTS A3720 5414 4-Sep NP_536341.1 P y n/d n/d
39 ARTS A4471 5414 4-Sep NP_536341.1 M y n/d n/d
40 ASAP1/Centaurin β4 A4227 50807, 314961, 13196